Motoo Yamasaki

This inventor holds 77 USPTO granted patents and 8 published patent applications, plus 5 CIPO patents and 12 EPO patents, primarily in Antibody Engineering (CPC class C07K). Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Hakko Kirin Co., Limited, University of Miyazaki. Active years: 1993-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motoo Yamasaki. Retrieved from https://idiyas.com/inventor/motoo-yamasaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 77 (Patent Applications = 8)

% Patents Active = 55.8

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 14)

Average Co-Inventor Count = 6.1

ph-index = 18

Forward Citations = 1,175(Granted Patents)

Forward Citations (Not Self Cited) = 881(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Toyko, JP (1998 - 1999)
Chiyoda-ku, JP (2012)
Tokyo, JP (1993 - 2014)
Machida, JP (1996 - 2019)
Shizuoka, JP (2015 - 2019)
Miyazaki, JP (2020 - 2023)

Company Filing History:

36 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

35 out of 272

Kyowa Hakko Kirin Co., Limited

patents

4 out of 36

University of Miyazaki

patents

4. 2 out of 104

Kyowa Hakko Bio Co., Ltd.

patents

5. 1 out of 8

Techno Network Shikoku Co., Ltd.

patents

6. 1 out of 1

Tecno Network Shikoku Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 1993-2024

Loading Chart...

Areas of Expertise:

Adrenomedullin Derivative

Antibody Composition

Glycoengineered Antibody

Cellular Cytotoxicity

Functional Immune Molecules

Fucosylation

Recombinant Antibody

Platelet Production

Th2-Mediated Disease

RNAi

Chemically Modified Polypeptides

Branched Polyalkylene Glycols

77 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171836 - Long-acting adrenomedullin derivative (2024-12-24),

2. 11578112 - Long-acting adrenomedullin derivative conjugated with Fc region of immunoglobulin (2023-02-14),

3. 11478551 - Long-acting adrenomedullin derivative (2022-10-25),

4. 10842879 - Long-acting adrenomedullin derivative (2020-11-24),

5. 10233475 - Antibody composition-producing cell (2019-03-19),

6. 10233247 - Method of modulating the activity of functional immune molecules (2019-03-19),

7. 10233246 - Antibody and antibody fragment introduced new modification sites (2019-03-19),

8. 9409982 - Antibody composition-producing cell (2016-08-09),

9. 9150639 - Antibody and antibody fragment introduced new modification sites (2015-10-06),

10. 8895266 - Antibody composition-producing cell (2014-11-25),

11. 8679491 - Method of modulating the activity of functional immune molecules (2014-03-25),

12. 8632996 - Method for producing recombinant antibody and antibody fragment thereof (2014-01-21),

13. 8367407 - Cells with altered fucosylation and producing antibodies therefrom (2013-02-05),

14. 8329443 - Antibody composition-producing cell (2012-12-11),

15. 8197814 - Method for treating the Th2-mediated disease (2012-06-12),

As the AI assistant of idiyas.com, let's dive into the world of innovation and invention with a focus on the visionary inventor, Motoo Yamasaki.

Title:

Unveiling the Legacy of Visionary Inventor Motoo Yamasaki

Introduction:

Motoo Yamasaki, a trailblazing inventor renowned for his groundbreaking contributions to technology, hails from Machida, Japan. With an impressive portfolio of 73 patents under his belt, Yamasaki's inventive spirit has consistently pushed the boundaries of what's possible in the realm of science and technology.

Latest Patents:

Yamasaki's recent patents showcase his ingenuity and expertise in the field. One notable invention involves introducing new modification sites on antibodies and antibody fragments, allowing for enhanced binding of macromolecular groups with high efficiency. Another patent focuses on a method of modulating the activity of functional immune molecules, offering new avenues for controlling and enhancing the functions of critical immunological entities.

Career Highlights:

Having worked with esteemed companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kirin Co., Limited, Yamasaki has left an indelible mark on the industry through his innovative projects and groundbreaking research. His collaborative efforts with industry leaders have led to the development of cutting-edge technologies that continue to shape the landscape of modern innovation.

Collaborations:

Throughout his career, Yamasaki has had the privilege of collaborating with talented individuals who share his passion for innovation. Notable coworkers include Nobuo Hanai and Kazuyasu Nakamura, whose collective expertise has enriched the collaborative projects and fueled the success of Yamasaki's inventive endeavors.

Conclusion:

In conclusion, Motoo Yamasaki's unwavering dedication to innovation and his penchant for excellence have established him as a visionary inventor at the forefront of technological advancement. His inventive spirit, coupled with his collaborative efforts and industry expertise, has positioned him as a driving force in shaping the future of technology.

Profile summary based on public USPTO records.